(19)
(11) EP 3 445 351 A1

(12)

(43) Date of publication:
27.02.2019 Bulletin 2019/09

(21) Application number: 17719692.0

(22) Date of filing: 19.04.2017
(51) International Patent Classification (IPC): 
A61K 31/198(2006.01)
A61P 43/00(2006.01)
(86) International application number:
PCT/GB2017/051090
(87) International publication number:
WO 2017/182802 (26.10.2017 Gazette 2017/43)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 19.04.2016 GB 201606834

(71) Applicant: Intrabio Ltd
Begbroke, Oxfordshire OX5 1PF (GB)

(72) Inventors:
  • FACTOR, Mallory
    Oxford Oxfordshire OX2 6UL (GB)
  • STRUPP, Michael
    D-81377 Munich (DE)

(74) Representative: Finnegan Europe LLP 
1 London Bridge
London SE1 9BG
London SE1 9BG (GB)

   


(54) ACETYL-LEUCINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR IMPROVED MOBILITY AND COGNITIVE FUNCTION